-
公开(公告)号：KR1020120040980A
公开(公告)日：2012-04-30
申请号：KR1020100102522
申请日：2010-10-20
Applicant: 한국과학기술연구원
IPC: C07D471/04 , A61K31/437 , A61P35/00
Abstract: PURPOSE: A pyrrolo[3,2-c]pyridine derivative and a pharmaceutical composition containing the same are provided to ensure anti-proliferatioin activity of melanoma and to prevent or treat melanoma. CONSTITUTION: A pyrrolo[3,2-c]pyridine derivative is denoted by chemical formula I. A method for preparing the pyrrolo[3,2-c]pyridine derivative of chemical formula I' or pharmaceutically acceptable salt thereof comprises: a step of reacting 4-chloro-1-pyrrolo[2,3-b]pyridine of chemical formula II with nitroaniline to prepare a compound of chemical formula III; a step of reacting a compound of chemical formula III with benzoyl chloride to prepare a compound of chemical formula IV; a step of reducing the compound of chemical formula IV to prepare a compound of chemical formula V; and a step of reacting the compound of chemical formula V with a compound of chemical formula VI or formula VII.
Abstract translation: 目的：提供吡咯并[3,2-c]吡啶衍生物和含有它们的药物组合物，以确保黑色素瘤的抗增殖活性并预防或治疗黑素瘤。 构成：化学式I表示吡咯并[3,2-c]吡啶衍生物。制备化学式I'吡咯并[3,2-c]吡啶衍生物或其药学上可接受的盐的方法包括： 使化学式II的4-氯-1-吡咯并[2,3-b]吡啶与硝基苯胺反应制备化学式Ⅲ化合物; 使化学式III的化合物与苯甲酰氯反应以制备化学式IV的化合物的步骤; 降低化学式IV化合物以制备化学式V的化合物的步骤; 以及使化学式V的化合物与化学式VI或式VII的化合物反应的步骤。
-
2.发明公开신규 피롤로[3,2-ｂ]피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 흑색종 예방 또는 치료용 약학적 조성물 失效新型吡咯并[3,2-B]吡啶衍生物或其药学上可接受的盐，其制备方法和药物组合物，用于预防或治疗含有作为活性成分的梅毒
公开(公告)号：KR1020100047998A
公开(公告)日：2010-05-11
申请号：KR1020080106962
申请日：2008-10-30
Applicant: 한국과학기술연구원
IPC: C07D487/04
Abstract: PURPOSE: A novel pyrollo[3,2-b]pyridine derivative and a pharmaceutical composition for preventing or treating melanoma containing the same are provided to ensure high anti-proliferative activity to melanoma cells. CONSTITUTION: A pyrollo(3,2-b)pyridine derivative is denoted by chemical formula 1. A method for preparing the pirrolo(3,2,-b)pyridine derivative comprises: a step of coupling 1-iodine-4-nitrobenze to a compound of chemical formula 2 to obtain a compound of chemical formula 3; a step of reducing the compound of chemical formula 3 to obtain a compound of chemical formula 4; and a step of coupling the compound of chemical formula 4 with a phenylcarboxylic acid or amine derivative which trifluoromethyl, halogen, morpholine, piperazine. A pharmaceutical composition for preventing or treating melanoma contains the pyrollo(3,2-b)pyridine derivative or pharmaceutically acceptable salt as an active ingredient.
Abstract translation: 目的：提供一种新型的吡咯并[3,2-b]吡啶衍生物和用于预防或治疗含有此类黑色素瘤的药物组合物，以确保对黑素瘤细胞的高抗增殖活性。 构成：吡咯（3,2-b）吡啶衍生物由化学式1表示。制备吡罗咯（3,2，-b）吡啶衍生物的方法包括：将1-碘-4-硝基苯偶联到 化学式2的化合物，得到化学式3的化合物; 还原化学式3的化合物以获得化学式4的化合物的步骤; 以及将化学式4的化合物与三氟甲基，卤素，吗啉，哌嗪的苯基羧酸或胺衍生物偶合的步骤。 用于预防或治疗黑素瘤的药物组合物含有吡罗洛（3,2-b）吡啶衍生物或其药学上可接受的盐作为活性成分。
-
公开(公告)号：KR101262931B1
公开(公告)日：2013-05-09
申请号：KR1020110003369
申请日：2011-01-13
Applicant: 한국과학기술연구원 , 전남대학교산학협력단
Abstract: 본발명은약물방출조절용다중코팅스텐트및 그의제조방법에관한것이다. 일구체예에따른약물방출조절용다중코팅스텐트에의하면, 생체내에서서로다른약물의방출을효율적으로정밀하게조절할수 있다.
-
公开(公告)号：KR101253282B1
公开(公告)日：2013-04-10
申请号：KR1020110037976
申请日：2011-04-22
Applicant: 한국과학기술연구원
Abstract: 본 발명은 생분해성 고분자 및 피톤치드의 혼합물을 포함하는 스텐트에 관한 것이다. 일 구체예에 따른 피톤치드 방출 스텐트에 의하면, 생체 내에서 피톤치드가 더욱 효율적으로 방출될 수 있다.
-
Patent Agency Ranking
公开(公告)号：KR101178793B1
公开(公告)日：2012-08-31
申请号：KR1020110027886
申请日：2011-03-29
CPC classification number: A61F2/82 , A61F2240/001 , A61F2250/0067 , A61F2310/00011 , A61F2310/00976 , A61L31/022 , A61L31/10 , A61L31/16
Abstract: PURPOSE: A method for coating heparin on the surface of a stent is provided to maintain a blood clot coagulation effect by improving heparin attachment stability. CONSTITUTION: A method for coating heparin on the surface of a stent is as follows. A coating solution is prepared by adding EDC(1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride) and NHS(N-hydroxysulfosuccinimide) to a mixture solution of heparin and dopamine. A metal stent is dipped in the coating solution. The metal stent is made of a material selected from a group consisting of stainless steel, Co-Cr alloy, tantalum, and gold.
Abstract translation: 目的：提供一种在支架表面涂覆肝素的方法，以通过改善肝素附着稳定性来维持凝血凝血作用。 构成：在支架表面涂覆肝素的方法如下。 通过将EDC（1-乙基-3-（3-二甲基氨基丙基）碳二亚胺盐酸盐）和NHS（N-羟基磺基琥珀酰亚胺）加入到肝素和多巴胺的混合溶液中来制备涂布溶液。 将金属支架浸入涂布溶液中。 金属支架由选自不锈钢，Co-Cr合金，钽和金的材料制成。
-
公开(公告)号：KR1020120082086A
公开(公告)日：2012-07-23
申请号：KR1020110003369
申请日：2011-01-13
Applicant: 한국과학기술연구원 , 전남대학교산학협력단
CPC classification number: A61F2/82 , A61F2240/001 , A61F2250/0067 , A61F2310/0097 , A61L31/022 , A61L31/10 , A61L31/16
Abstract: PURPOSE: A multiple coating stent for controlling the medicine emission, and a manufacturing method thereof are provided to form three coating layers of different drugs by emitting ultrasonic waves. CONSTITUTION: A manufacturing method of a multiple coating stent for controlling the medicine emission comprises the following steps: ultrasonic wave-spraying a mixed solution of a first drug and a biodegradable polymer on the surface of a stent for forming a first coating layer; ultrasonic wave-spraying a biodegradable polymer solution on the upper side of the first coating layer for forming a second coating layer; ultrasonic wave-spraying a second mixed solution of a second drug and the biodegradable polymer on the upper side of the second coating layer for forming a third coating layer; and forming a fourth coating layer on the third coating layer using a biodegradable polymer. The first or second drug is selected from polyvinyl alcohol, saponin, carboxymethyl cellulose, or mono grylceride.
Abstract translation: 目的：提供一种用于控制药物发射的多层涂层支架及其制造方法，通过发射超声波形成不同药物的三个涂层。 构成：用于控制药物发射的多层涂层支架的制造方法，包括以下步骤：在用于形成第一涂层的支架的表面上超声波喷射第一药物和生物降解性聚合物的混合溶液; 在第一涂层的上侧超声波喷射可生物降解的聚合物溶液，以形成第二涂层; 将第二药物和生物降解性聚合物的第二混合溶液超声波喷涂在第二涂层的上侧，以形成第三涂层; 以及使用可生物降解的聚合物在所述第三涂层上形成第四涂层。 第一种或第二种药物选自聚乙烯醇，皂角苷，羧甲基纤维素或单烯酸甘油酯。
-
7.发明授权신규 피롤로[3,2-ｂ]피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 흑색종 예방 또는 치료용 약학적 조성물 失效新的吡咯并[3,2-b]吡啶衍生物或其药学上可接受的盐，其制备方法和用于预防或治疗含有其作为活性成分的黑素瘤的药物组合物
公开(公告)号：KR100994687B1
公开(公告)日：2010-11-17
申请号：KR1020080106962
申请日：2008-10-30
Applicant: 한국과학기술연구원
IPC: C07D487/04
Abstract: 본 발명은 신규 피롤로[3,2-ｂ]피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 흑색종 예방 또는 치료용 약학적 조성물에 관한 것으로, 더욱 상세하게는 하기 화학식 1로 표시되는 신규 피롤로[3,2-ｂ]피리딘 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 흑색종 예방 또는 치료용 약학적 조성물에 관한 것이다. 본 발명에 따른 피롤로[3,2-b]피리딘 유도체는 흑색종 세포에 대하여 뛰어난 흑색종 항증식 활성을 나타내며, 종래 흑색종 치료제로 사용되는 소라페닙에 비하여 10배 이상의 흑색종 항증식 활성을 나타내기 때문에 흑색종 예방 또는 치료에 유용하게 사용될 수 있다.
[화학식 1]
(상기 화학식 1에서 R
1 및 R
2 는 본 명세서에서 정의한 바와 같다)
피롤로[3,2-b]피리딘 유도체, DTIC, 흑색종, 항증식효과-
公开(公告)号：KR1020120119786A
公开(公告)日：2012-10-31
申请号：KR1020110037976
申请日：2011-04-22
Applicant: 한국과학기술연구원
CPC classification number: A61F2/82 , A61F2250/0067 , A61F2310/00011 , A61F2310/0097 , A61L31/022 , A61L31/10 , A61L31/14 , A61L31/16
Abstract: PURPOSE: A phytoncide releasing stent is provided to more efficiently emit phytoncide in a living body. CONSTITUTION: A phytoncide releasing stent comprises a coating layer in which the mixture of phytoncide and biodegradable polymer is coated on the surface thereof. A stent is made of a metal material selected from stainless steel, cobalt-chrome, platinum-chrome, tantalum, titanium, nitinol, gold, platinum, silver, and their alloy. The biodegradable polymer is selected from a group consisting of polyglycolic acid, poly-L-lactic acid, poly-D-lactic acid, poly-D,L-lactic acid, poly-e-carprolactone, polylactic acid-glycolic acid copolymer, poly-L-lactic acid-e-caprolactone copolymer, polyethylene glycol, polyamino acid, polyanhydride, polyortho ester, polydioxanone, polyphosphazene, cellulose acetate butylate, cellulose triacetate, and their copolymer.
Abstract translation: 目的：提供一种放液剂释放支架，以更有效地在活体中释放出杀藻素。 构成：放液剂释放支架包括涂层，其中植物保护剂和可生物降解聚合物的混合物在其表面上被涂覆。 支架由选自不锈钢，钴铬，铂铬，钽，钛，镍钛诺，金，铂，银及其合金的金属材料制成。 生物降解性聚合物选自聚乙醇酸，聚-L-乳酸，聚-D-乳酸，聚-D，L-乳酸，聚己内酯，聚乳酸 - 乙醇酸共聚物，聚 -L-乳酸 - ε-己内酯共聚物，聚乙二醇，聚氨基酸，聚酐，聚缩醛酯，聚二恶烷酮，聚磷腈，乙酸纤维素丁酸酯，三乙酸纤维素及其共聚物。
-
公开(公告)号：KR101173678B1
公开(公告)日：2012-08-13
申请号：KR1020100102522
申请日：2010-10-20
Applicant: 한국과학기술연구원
IPC: C07D471/04 , A61K31/437 , A61P35/00
Abstract: 본 발명은 흑색종에 대한 항증식 활성이 뛰어난 피롤로[3,2-c]피리딘 유도체 또는 이의 약제학적으로 허용가능한 염, 이의 제조 방법 및 이를 포함하는 약제학적 조성물에 관한 것이다.
-
-
-
-
-
-
-
-
Search Results
9
records
(took 0.018 seconds)
